Please use this identifier to cite or link to this item:
Title: Dupilumab Improves Nasal Polyp Burden and Asthma Control in Patients With CRSwNP and AERD
Author: Laidlaw, Tanya M.
Mullol i Miret, Joaquim
Fan, Chunpeng
Zhang, Donghui
Amin, Nikhil
Khan, Asif
Chao, Jingdong
Mannent, Leda P.
Keywords: Sinusitis
Issue Date: 4-Apr-2019
Publisher: Elsevier
Abstract: In the difficult-to-treat subgroup of patients with chronic rhinosinusitis with nasal polyps (CRSwNP) and comorbid aspirin-exacerbated respiratory disease, dupilumab significantly improved CRSwNP disease outcomes, along with asthma control and lung function. This is preliminary evidence of the effect of dupilumab in patients with CRSwNP and comorbid aspirin- exacerbated respiratory disease.
Note: Versió postprint del document publicat a:
It is part of: The Journal of Allergy and Clinical Immunology: In Practice, 2019, vol. 7, num. 7, p. 2462-2465.e1
Related resource:
Appears in Collections:Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Files in This Item:
File Description SizeFormat 
12474_4793271_Amin.pdf800.23 kBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons